The prevalence of mild cognitive impairment in breast cancer patients receiving chemotherapy according to the criteria of the National Institute on Aging-Alzheimer's Association (NIA-AA).

Saved in:
Bibliographic Details
Title: The prevalence of mild cognitive impairment in breast cancer patients receiving chemotherapy according to the criteria of the National Institute on Aging-Alzheimer's Association (NIA-AA).
Authors: Albers EAC; Divison of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. e.albers@nki.nl., Kieffer JM; Divison of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Schagen SB; Divison of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Department of Psychology, University of Amsterdam, Amsterdam, The Netherlands.
Source: Journal of cancer survivorship : research and practice [J Cancer Surviv] 2025 Dec; Vol. 19 (6), pp. 1948-1955. Date of Electronic Publication: 2024 Apr 26.
Publication Type: Journal Article
Journal Info: Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 101307557 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1932-2267 (Electronic) Linking ISSN: 19322259 NLM ISO Abbreviation: J Cancer Surviv Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1932-2267
DOI:10.1007/s11764-024-01608-0